4//SEC Filing
CLARKE JOHN K 4
Accession 0000950170-24-064235
CIK 0001339970other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 7:30 PM ET
Size
5.4 KB
Accession
0000950170-24-064235
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
CLARKE JOHN K
DirectorOther
Transactions
- Award
Stock Option (right to buy)
2024-05-22+24,000→ 24,000 totalExercise: $1.86Exp: 2034-05-22→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001219015
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 7:30 PM ET
- Size
- 5.4 KB